Cardio Diagnostics
CDIO
14 hedge funds and large institutions have $2.3M invested in Cardio Diagnostics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.01% less ownership
Funds ownership: 0.27% → 0.26% (-0.01%)
44% less capital invested
Capital invested by funds: $4.12M → $2.3M (-$1.82M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$44.5K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$32.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$26.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$23.8K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$114K |
| 2 |
Squarepoint
New York
|
-$97.4K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$37.6K |
CDIO Hedge Fund Activity: Q1 2024 in Review
14 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q1 2024, worth a combined $2.3M — down 44% from $4.12M a quarter earlier.
Fund positioning in CDIO was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 1 trimmed.
The largest buyer was State Street, adding an estimated $44.5K. The largest seller was Linden Advisors, exiting entirely with an estimated $114K sold.
- 14 institutional investors held Cardio Diagnostics (CDIO) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $2.3M of Cardio Diagnostics stock for Q1 2024, down 44% quarter-over-quarter.
- 2 funds opened new Cardio Diagnostics positions in Q1 2024 and 2 closed out, a net change of 0 holders.
- The largest Cardio Diagnostics buyer in Q1 2024 was State Street, an estimated $44.5K added.
- The largest Cardio Diagnostics seller in Q1 2024 was Linden Advisors, an estimated $114K sold.
Based on aggregated 13F filings for Q1 2024.